Oscar Health (NYSE:OSCR – Get Free Report) was downgraded by investment analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating in a research note issued on Thursday, Marketbeat.com reports. They currently have a $16.00 target price on the stock, down from their previous target price of $20.00. Wells Fargo & Company‘s price objective would suggest a potential upside of 20.98% from the stock’s previous close.
Separately, Jefferies Financial Group initiated coverage on Oscar Health in a report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price objective on the stock. Two research analysts have rated the stock with a sell rating, three have given a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $20.19.
Read Our Latest Stock Analysis on Oscar Health
Oscar Health Stock Performance
Oscar Health (NYSE:OSCR – Get Free Report) last issued its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. As a group, equities research analysts expect that Oscar Health will post 0.69 earnings per share for the current fiscal year.
Institutional Trading of Oscar Health
A number of hedge funds have recently modified their holdings of the company. Brooklyn FI LLC bought a new stake in shares of Oscar Health in the 4th quarter worth approximately $441,000. Toronto Dominion Bank bought a new stake in shares of Oscar Health in the 4th quarter worth approximately $1,008,000. Tidal Investments LLC bought a new stake in shares of Oscar Health in the 4th quarter worth approximately $419,000. Thrive Capital Management LLC lifted its position in shares of Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after buying an additional 1,588,395 shares during the period. Finally, Scion Asset Management LLC bought a new position in shares of Oscar Health during the 4th quarter worth approximately $2,688,000. Institutional investors own 75.70% of the company’s stock.
Oscar Health Company Profile
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Recommended Stories
- Five stocks we like better than Oscar Health
- Why Invest in 5G? How to Invest in 5G Stocks
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- What is diluted earnings per share (Diluted EPS)?
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- What is the Dogs of the Dow Strategy? Overview and Examples
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.